Granulocyte-macrophage colony-stimulating factor priming plus papillomavirus E6 DNA vaccination: Effects on papilloma formation and regression in the cottontail rabbit papillomavirus-rabbit model

Journal of Virology

Volumn 74, Issue 18, 2000, Pages 8700-8708

  Leachman, S A ^a   Tigelaar, R E ^a   Shlyankevich, M ^a   Slade, M D ^a   Irwin, M ^a   Chang, E ^a   Wu, T C ^a   Xiao, W ^a   Pazhani, S ^a   Zelterman, D ^a   Brandsma, J L ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA VACCINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; INFECTION PREVENTION; NONHUMAN; PAPILLOMA; PAPILLOMA VIRUS; PRIORITY JOURNAL; RABBIT; SURVIVAL TIME; VACCINATION;

ANIMALS; BIOPSY; COTTONTAIL RABBIT PAPILLOMAVIRUS; DISEASE MODELS, ANIMAL; DISEASE-FREE SURVIVAL; DNA, VIRAL; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; PAPILLOMA; PAPILLOMAVIRUS INFECTIONS; RABBITS; TUMOR VIRUS INFECTIONS; VACCINES, DNA; VIRAL VACCINES;

EID: 0033864179     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.18.8700-8708.2000     Document Type: Article

References (73)

1. Immune responsiveness to a murine mammary carcinoma modified to express B7-1, interleukin-12, or GM-CSF
2. HPV 16 infection and progression of cervical intra-epithelial neoplasia: Analysis of HLA polymorphism and HPV 16 E6 sequence variants
3. Animal models for human papillomavirus vaccine development
4. Animal models of human-papillomavirus-associated oncogenesis
5. Use of a rapid, efficient inoculation method to induce papillomas by cottontail rabbit papillomavirus DNA shows that the E7 gene is required
6. The rabbit viral skin papillomas and carcinomas: A model for the immunogenetics of HPV-associated carcinogenesis
7. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: Enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1
8. GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells
9. DNA-based immunization by in vivo transfection of dendritic cells
10. Selected strategies to augment polynucleotide immunization
11. Gene vaccination with naked plasmid DNA: Mechanism of CTL priming
12. Plasmid DNA expression systems for the purpose of immunization
13. Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts
14. Combined chemokine and cytokine gene transfer enhances antitumor immunity
15. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells
16. Protection against papillomavirus with a polynucleotide vaccine
17. DNA vaccines
18. Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting antitumor immunity
19. Granulocyte-macrophage colony-stimulating factor. Preliminary observations on the influences of dose, schedule, and route of administration in patients receiving cyclophosphamide and carboplatin
20. Dermatology and general medicine, 4th ed
21. Priming of cytotoxic T lymphocytes by DNA vaccines: Requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes
22. Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids
23. Structural and mutational analysis of E2 transactivating proteins of papillomaviruses reveals three distinct functional domains
24. Study of the E2 gene product of the cottontail rabbit papillomavirus reveals a common mechanism of transactivation among papillomaviruses
25. Linkage of regression and malignant conversion of rabbit viral papillomas to MHC class II genes
26. Characterization of transformation function of cottontail rabbit papillomavirus E5 and E8 genes
27. Intramuscular injection of plasmid DNA encoding cottontail rabbit papillomavirus E1, E2, E6 and E7 induces T cell-mediated but not humoral immune responses in rabbits
28. Protection of rabbits from viral challenge by gene gun-based intracutaneous vaccination with a combination of cottontail rabbit papillomavirus E1, E2, E6, and E7 genes
29. DQA1 and DQB1 genes in patients with squamous cell carcinoma of the cervix: Relationship to human papillomavirus infection and prognosis
30. Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells
31. Transcription patterns of human papillomavirus type 16 in genital intraepithelial neoplasia: Evidence for promoter usage within the E7 open reading frame during epithelial differentiation
32. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: Results from a case-control study conducted in the United States
33. Transcription of the E6 and E7 genes of human papillomavirus type 6 in anogenital condylomata is restricted to undifferentiated cell layers of the epithelium
34. Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases
35. Enhanced CTL responses mediated by plasmid DNA immunogens encoding costimulatory molecules and cytokines
36. The dominant role of bone marrow-derived cells in CTL induction following plasmid DNA immunization at different sites
37. In vivo particlemediated cytokine gene transfer into canine oral mucosa and epidermis
38. Vaccination against polyoma-and papillomavirus-induced tumors using vaccinia recombinants expressing non-structural proteins
39. DNA vaccines for papilloma-viruses
40. Genital human papillomavirus infection
41. DNA vaccination with cytokine fusion constructs biases the immune response to ovalbumin
42. Particle-mediated gene transfer of granulocyte-macrophage colony-stimulating factor cDNA to tumor cells: Implications for a clinically relevant tumor vaccine
43. Phase I/IB study of immunization with autologous tumor cells transfected with the GM-CSF gene by particle-mediated transfer in patients with melanoma or sarcoma
44. DNA vaccines - A modern gimmick or a boon to vaccinology?
45. Inhibition by methylprednisolone of regression of the Shope rabbit papilloma
46. Identification of three transforming proteins encoded by cottontail rabbit papillomavirus
47. Cervical cancer and human papillomavirus: Epidemiological evidence and perspectives for prevention
48. Intranasal immunization of a DNA vaccine with IL-12- and granulocyte-macrophage colony-stimulating factor (GM-CSF)-expressing plasmids in liposomes induces strong mucosal and cell-mediated immune responses against HIV-1 antigens
49. Exposing the immunology of naked DNA vaccines
50. Cytokines and costimulatory molecules as genetic adjuvants
51. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow
52. DNA vaccines
53. In vitro expansion of CD13+CD33+ dendritic cell precursors from multipotent progenitors is regulated by a discrete fas-mediated apoptotic schedule
54. Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy
55. Anogenital papillomavirus infection and neoplasia in immunodeficient women: An update
56. Protective immunity against heterologous challenge with encephalomyocarditis virus by VP1 DNA vaccination: Effect of coinjection with a granulocyte-macrophage colony stimulating factor gene
57. In situ hybridization detection of human papillomavirus DNAs and messenger RNAs in genital condylomas and a cervical carcinoma
58. Epidermal Langerhans cell development and differentiation
59. Generation of human dendritic cells/Langerhans cells from circulating CD34+ hematopoietic progenitor cells
60. Intracutaneous vaccination of rabbits with the cottontail rabbit papillomavirus (CRPV) L1 gene protects against virus challenge
61. Intracutaneous vaccination of rabbits with the E6 gene of cottontail rabbit papillomavirus provides partial protection against virus challenge
62. Amplification of T-cell and antibody responses in DNA-based immunization with HIV-1 Nef by co-injection with a GM-CSF expression vector
63. DNA immunization induces protective immunity against B-cell lymphoma
64. Idiotype/granulocyte-macrophage colonystimulating factor fusion protein as a vaccine for B-cell lymphoma
65. Evidence that granulocyte macrophage-colony-stimulating factor regulates the distribution and differentiated state of dendritic cells/Langerhans cells in human lung and lung cancers
66. Immunomanipulative strategies for the control of human papillomavirus associated cervical disease
67. Papillomaviruses and malignant progression. I. Cottontail rabbit (Shope) papillomavirus
68. Granulocyte/macrophage colony-stimulating factor is essential for the viability and function of cultured murine epidermal Langerhans cells
69. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma. A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens
70. Papilloma formation by cottontail rabbit papillomavirus requires E1 and E2 regulatory genes in addition to E6 and E7 transforming genes
71. Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines
72. Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits
73. Papillomavirus infections - A major cause of human cancers